How long should breast cancer patients whose surgeries are delayed due to COVID-19 remain on neoadjuvant endocrine therapy?

How long to continue neoadjuvant endocrine therapy (NET) when it was initiated for the purposes of COVID-19 management depends on several variables, including whether the tumor is at least stable on NET (if not, then conversion to surgery or chemotherapy is appropriate), and what the COVID-19 trajec...

I completely agree with @Dr. First Last here. We tended to do this with older women who are/were not fit for surgery in the pre-COVID era. There is no reason not to continue this practice now.

I strongly agree with @Dr. First Last's recommendation. Multiple clinical trials showed the safety and efficacy of this approach.